BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 15632797)

  • 1. Retention in publicly funded methadone maintenance treatment in two Western States.
    Deck D; Carlson MJ
    J Behav Health Serv Res; 2005; 32(1):43-60. PubMed ID: 15632797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Access to publicly funded methadone maintenance treatment in two western states.
    Deck D; Carlson MJ
    J Behav Health Serv Res; 2004; 31(2):164-77. PubMed ID: 15255224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methadone maintenance and state Medicaid managed care programs.
    McCarty D; Frank RG; Denmead GC
    Milbank Q; 1999; 77(3):341-62, 274. PubMed ID: 10526548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Financial factors and the implementation of medications for treating opioid use disorders.
    Knudsen HK; Roman PM
    J Addict Med; 2012 Dec; 6(4):280-6. PubMed ID: 22810057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Access to substance abuse treatment services under the Oregon Health Plan.
    Deck DD; McFarland BH; Titus JM; Laws KE; Gabriel RM
    JAMA; 2000 Oct; 284(16):2093-9. PubMed ID: 11042758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medicaid Coverage of Methadone Maintenance and the Use of Opioid Agonist Therapy Among Pregnant Women in Specialty Treatment.
    Bachhuber MA; Mehta PK; Faherty LJ; Saloner B
    Med Care; 2017 Dec; 55(12):985-990. PubMed ID: 29135769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medicaid coverage, methadone maintenance, and felony arrests: outcomes of opiate treatment in two states.
    Deck D; Wiitala W; McFarland B; Campbell K; Mullooly J; Krupski A; McCarty D
    J Addict Dis; 2009; 28(2):89-102. PubMed ID: 19340671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users.
    Banta-Green CJ; Maynard C; Koepsell TD; Wells EA; Donovan DM
    Addiction; 2009 May; 104(5):775-83. PubMed ID: 19344438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elimination of methadone benefits in the Oregon Health Plan and its effects on patients.
    Fuller BE; Rieckmann TR; McCarty DJ; Ringor-Carty R; Kennard S
    Psychiatr Serv; 2006 May; 57(5):686-91. PubMed ID: 16675764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Day treatment versus enhanced standard methadone services for opioid-dependent patients: a comparison of clinical efficacy and cost.
    Avants SK; Margolin A; Sindelar JL; Rounsaville BJ; Schottenfeld R; Stine S; Cooney NL; Rosenheck RA; Li SH; Kosten TR
    Am J Psychiatry; 1999 Jan; 156(1):27-33. PubMed ID: 9892294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retention of patients who entered methadone maintenance via an interim methadone clinic.
    Friedman P; Des Jarlais DC; Peyser NP; Nichols SE; Drew E; Newman RG
    J Psychoactive Drugs; 1994; 26(2):217-21. PubMed ID: 7931866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methadone medical maintenance in primary care. An implementation evaluation.
    Merrill JO; Jackson TR; Schulman BA; Saxon AJ; Awan A; Kapitan S; Carney M; Brumback LC; Donovan D
    J Gen Intern Med; 2005 Apr; 20(4):344-9. PubMed ID: 15857492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On-site medical care in methadone maintenance: associations with health care use and expenditures.
    Gourevitch MN; Chatterji P; Deb N; Schoenbaum EE; Turner BJ
    J Subst Abuse Treat; 2007 Mar; 32(2):143-51. PubMed ID: 17306723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implications of managed care for methadone treatment. Findings from five case studies in New York State.
    Zarkin GA; Dunlap LJ
    J Subst Abuse Treat; 1999; 17(1-2):25-35. PubMed ID: 10435250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is conventional wisdom wrong? Coverage for substance abuse treatment under Medicaid managed care.
    Maglione M; Ridgely MS
    J Subst Abuse Treat; 2006 Jun; 30(4):285-90. PubMed ID: 16716842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of managed care on publicly funded outpatient adolescent substance abuse treatment: service use and six-month outcomes in Oregon and Washington.
    Carlson MJ; Gabriel RM; Deck DD; Laws KE; D'Ambrosio R
    Med Care Res Rev; 2005 Jun; 62(3):320-38. PubMed ID: 15894707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medicaid Coverage for Methadone Maintenance and Use of Opioid Agonist Therapy in Specialty Addiction Treatment.
    Saloner B; Stoller KB; Barry CL
    Psychiatr Serv; 2016 Jun; 67(6):676-9. PubMed ID: 26927578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes for medicaid clients with substance abuse problems before and after managed care.
    McFarland BH; Deck DD; McCamant LE; Gabriel RM; Bigelow DA
    J Behav Health Serv Res; 2005; 32(4):351-67. PubMed ID: 16215446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medicaid coverage and access to publicly funded opiate treatment.
    Deck DD; Wiitala WL; Laws KE
    J Behav Health Serv Res; 2006 Jul; 33(3):324-34. PubMed ID: 16752109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Users of free treatment slots at a community-based methadone maintenance clinic.
    Wells EA; Fleming C; CalsyƄ DA; Jackson TR; Saxon AJ
    J Subst Abuse Treat; 1995; 12(1):13-8. PubMed ID: 7752292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.